NYSE:OSTX | Income Statement | OS Therapies Inc

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$6.07M-$8.58M-$56,774.00-$8.63M-$0.20-$0.2043,904,159
2026-03-31$7.35M-$10.17M-$228,893.00-$10.4M-$0.27-$0.2738,674,663
2025-12-31$8.8M-$11.99M-$1.47M-$13.46M-$0.41-$0.411,862,820
2025-09-30$3.76M-$6.88M$65.00-$6.88M-$0.21-$0.2131,956,686
2025-06-30$2.5M-$4.84M$302,106.00-$4.54M-$0.19-$0.1925,114,460
2025-03-31$1.31M-$5M$1.12M-$3.88M-$0.18-$0.1821,249,423
2024-12-31$870,469.00-$2.97M-$24,810.00-$2.99M-$0.64-$0.643,127,348-2,299,851
2024-09-30$1.21M-$2.44M-$437,839.00-$2.88M-$0.18-$0.1815,897,46015,897,460
2024-06-30$396,567.00-$779,800.00-$777,680.00-$1.56M-$0.26-$0.265,991,0415,991,041
2024-03-31$361,809.00-$630,232.00-$828,760.00-$1.46M-$0.25-$0.255,991,041
2023-12-31$1.02M-$1.16M-$307,534.00-$1.46M-$0.85-$0.85-5,096,906
2023-09-30$454,505.00-$622,208.00-$1.35M-$1.97M-$0.38-$0.385,340,0005,340,000
2023-06-30$992,896.00-$1.52M-$989,684.00-$2.51M-$0.47-$0.475,340,0005,340,000
2023-03-31$753,784.00-$1.05M-$798,938.00-$1.85M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$16.36M-$28.71M-$48,143.00-$28.75M-$0.98-$0.9829,253,292
2024-12-31$2.84M-$6.81M-$2.07M-$8.88M-$1.28-$1.2812,377,2996,950,100
2023-12-31$3.22M-$4.34M-$3.45M-$7.79M-$1.46-$1.465,429,248